What is Opus Genetics's R&D?

Opus Genetics (IRD) reported R&D of $10.58M in Q1 2026.

How has Opus Genetics's R&D changed year-over-year?

Opus Genetics's R&D increased by 33.0% year-over-year, from $7.95M to $10.58M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Opus Genetics IRD R&D

R&D at other companies

MeiraGTx Holdings plcMGTX

$31.98M-2.4%

4D Molecular TherapeuticsFDMT

$64.98M+59.7%

Opko HealthOPK

$29.2M-5.3%

Kodiak Sciences IncKOD

$48.55M+11.2%

Regeneron PharmaceuticalsREGN

$1.54B+16.3%

RegenxbioRGNX

$57.34M+8.0%

Segments

By product

See full

First Licensed Product$700K—

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's R&D?: Opus Genetics (IRD) reported R&D of $10.58M in Q1 2026.
How has Opus Genetics's R&D changed year-over-year?: Opus Genetics's R&D increased by 33.0% year-over-year, from $7.95M to $10.58M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.